NCT00003384View on ClinicalTrials.gov

Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer

NACompletedINTERVENTIONAL
Enrollment

684

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

January 31, 2011

Conditions
Precancerous ConditionStage 0 Cervical Cancer
Interventions
OTHER

Cervical Papanicolaou Test

Undergo Pap smear

PROCEDURE

Conization

Undergo cone biopsy

OTHER

Laboratory Biomarker Analysis

Correlative studies

Trial Locations (1)

85012

Gynecologic Oncology Group of Arizona, Phoenix

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00003384 - Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer | Biotech Hunter | Biotech Hunter